Mrtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mrtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mrtx Today - Breaking & Trending Today

Mirati Therapeutics (NASDAQ:MRTX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. MRTX has been the subject of a number of other reports. SVB Leerink reiterated a market perform rating and issued a $58.00 price […] ....

United States , Leerink Partnrs , Jamie Christensen , Stifel Nicolaus , Benjamin Hickey , Securities Exchange Commission , Mirati Therapeutics Company Profile , Mirati Therapeutics Inc , Exome Asset Management , Westchester Capital Management , Mirati Therapeutics , Free Report , Exchange Commission , Avenue Partners , Employees Retirement System , Asset Management , Get Free Report , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,

Rhenman & Partners Asset Management AB Increases Stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX)

Rhenman & Partners Asset Management AB grew its stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) by 25.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 175,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during […] ....

United States , Leerink Partnrs , Stifel Nicolaus , Benjamin Hickey , Jamie Christensen , Exchange Commission , Advisor Group Holdings Inc , Mirati Therapeutics Inc , Headlands Technologies , First Horizon Advisors Inc , Bluepath Capital Management , Securities Exchange Commission , Partners Asset Management , Mirati Therapeutics , Free Report , Horizon Advisors , Path Capital Management , Advisor Group Holdings , Group Holdings , Therapeutics Trading Down , Visit Holdingschannel , Mirati Therapeutics Daily , Nasdaq Mrtx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Brokerages Set Mirati Therapeutics, Inc. (NASDAQ:MRTX) Price Target at $60.00

Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) have earned an average recommendation of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Eleven analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price […] ....

United States , Jamie Christensen , Leerink Partnrs , Benjamin Hickey , Stifel Nicolaus , Acadian Asset Management , Mirati Therapeutics Inc , Quadrant Capital Group , Bluepath Capital Management , Securities Exchange Commission , First Horizon Advisors Inc , Mirati Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Capital Group , Horizon Advisors , Asset Management , Get Free , Mirati Therapeutics Daily , Nasdaq Mrtx ,

StockNews.com Initiates Coverage on Mirati Therapeutics (NASDAQ:MRTX)

StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts have also recently commented on MRTX. Piper Sandler cut shares of Mirati Therapeutics from an overweight rating to a neutral rating and […] ....

United States , Jamie Christensen , Benjamin Hickey , Leerink Partnrs , Piper Sandler , Us Bancorp , Mirati Therapeutics Inc , Blackrock Inc , Securities Exchange Commission , Acadian Asset Management , Advisor Group Holdings Inc , Mirati Therapeutics Company Profile , Metlife Investment Management , Mirati Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Exchange Commission , Group Holdings , Asset Management , Life Investment Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,

Mirati Therapeutics (NASDAQ:MRTX) Now Covered by StockNews.com

Stock analysts at StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Get Free Report) in a report released on Monday. The firm set a “sell” rating on the biotechnology company’s stock. MRTX has been the topic of a number of other reports. Stifel Nicolaus reaffirmed a “hold” rating and issued a $59.00 price […] ....

United States , Jamie Christensen , Benjamin Hickey , Leerink Partnrs , Stifel Nicolaus , Acadian Asset Management , Headlands Technologies , Mirati Therapeutics Inc , Bluepath Capital Management , First Horizon Advisors Inc , Securities Exchange Commission , Mirati Therapeutics , Get Free Report , Exchange Commission , Horizon Advisors , Asset Management , Path Capital Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage , Stocknews Com ,